Data Foundry

Drug recalls 2025

Testosterone Gel 1% — Class II drug recall D-0294-2025

Ongoing recall by Strides Pharma, Inc., reported 2025-04-02, distributed nationwide. Presence of foreign substance: Presence of Benzene.

Recall numberD-0294-2025
Product typeDrug
ClassificationClass II
StatusOngoing
Voluntary or mandatedVoluntary
Recalling firmStrides Pharma, Inc., Chestnut Ridge, NY, United States
Recall initiated2025-03-05
Classified2025-03-25
Reported by FDA2025-04-02
DistributedNationwide (US)
Reason classeschemical contamination
NDC64380-0151, 64380-0151-01, 64380-0151-02, 64380-0152, 64380-0152-01, 64380-0152-02
Lot numbers5501103A, 5501237A, 5501238A, 5501278A, 5501280A, 5501342A, 5501372A, 5501496A, 5501499A, 5501580A, 5501582A, 5501653A, 5501656A, 5501770A, 5501842A, 5501868A, 5501882A, 5501957A, 5502001A, 5502033A, 5502112A, 5502115A, 5502180A, 5502181A, APR-25, APR-26, AUG-25, AUG-26, DEC-25, FEB-26, JAN-26, JUL-25, JUL-26, JUN-25, MAR-25, MAY-25, MAY-26, NOV-26, OCT-25, OCT-26 and 1 more

Product

Testosterone Gel 1%, 5 grams, 30 Unit-dose Packets in a carton, Rx only, Distributed by: Strides Pharma Inc., East Brunswick, NJ, NDC 64380-152-02

Reason for recall

Presence of foreign substance: Presence of Benzene.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0294-2025. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.